New catheter could speed up heart procedure

NCT ID NCT07563257

Recruiting now Knowledge-focused Sponsor: Maxime Zabern Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study compares two catheters used during a common heart procedure for atrial fibrillation. The goal is to see if one catheter can confirm that the treatment worked faster than the current method. Thirty adults with persistent atrial fibrillation or atrial flutter will be enrolled, and each will have both catheters tested during their procedure.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Two mapping catheters (Optrell and Octaray) used during atrial fibrillation ablation
What this could lead to: If successful, this could make atrial fibrillation ablation procedures faster and more efficient by reducing the need for extra mapping steps.
What could go wrong: This is a small, early observational study with only 30 participants, so results may not apply to all patients. It compares tools already on the market, not a new treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION (AF) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

atrial fibrillation atrial flutter

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ATRIAL FIBRILLATION (AF)

Contacts and locations

Locations

Shamir Medical Center
RECRUITING

Be’er Ya‘aqov, Israel

More trials for these conditions

Other studies related to the condition(s) this trial covers.